Loading...

Silver Spike Investment Corp.

SSICNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$10.73
$0.13(1.27%)

Silver Spike Investment Corp. (SSIC) Stock Overview

Explore Silver Spike Investment Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.4/100

Key Financials

Market Cap66.7M
P/E Ratio9.09
EPS (TTM)$0.90
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$17.35

SSIC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Silver Spike Investment Corp. (SSIC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $17.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.09 and a market capitalization of 66.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;